Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Oncology's trials.
Booth B, Glassman R, Ma P. Booth B, et al. Among authors: glassman r. Nat Rev Drug Discov. 2003 Aug;2(8):609-10. doi: 10.1038/nrd1158. Nat Rev Drug Discov. 2003. PMID: 12908467 No abstract available.
Biotechnology: identifying advances from the hype.
Glassman RH, Sun AY. Glassman RH, et al. Nat Rev Drug Discov. 2004 Feb;3(2):177-83. doi: 10.1038/nrd1309. Nat Rev Drug Discov. 2004. PMID: 15040581 Review. No abstract available.
Wall Street's perspective on oncology drug development.
Glassman RH. Glassman RH. Clin Adv Hematol Oncol. 2007 May;5(5):369-71, 385. Clin Adv Hematol Oncol. 2007. PMID: 17673892 No abstract available.
Biomarkers in phase I oncology trials: signal, noise, or expensive distraction?
Ratain MJ, Glassman RH. Ratain MJ, et al. Among authors: glassman rh. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6545-8. doi: 10.1158/1078-0432.CCR-07-2133. Clin Cancer Res. 2007. PMID: 18006752 Free article. No abstract available.
A genetic revolution in healthcare.
Bhandari M, Garg R, Glassman R, Ma PC, Zemmel RW. Bhandari M, et al. Among authors: glassman r. Hosp Q. 2000 Spring;3(3):58-62. doi: 10.12927/hcq..16717. Hosp Q. 2000. PMID: 11494612 No abstract available.
Biomarkers in early cancer drug development: limited utility.
Glassman RH, Ratain MJ. Glassman RH, et al. Clin Pharmacol Ther. 2009 Feb;85(2):134-5. doi: 10.1038/clpt.2008.231. Clin Pharmacol Ther. 2009. PMID: 19151638 Review.
v-Crk, an effector of the nerve growth factor signaling pathway, delays apoptotic cell death in neurotrophin-deprived PC12 cells.
Glassman RH, Hempstead BL, Staiano-Coico L, Steiner MG, Hanafusa H, Birge RB. Glassman RH, et al. Cell Death Differ. 1997 Jan;4(1):82-93. doi: 10.1038/sj.cdd.4400203. Cell Death Differ. 1997. PMID: 16465214
Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways.
Hempstead BL, Birge RB, Fajardo JE, Glassman R, Mahadeo D, Kraemer R, Hanafusa H. Hempstead BL, et al. Among authors: glassman r. Mol Cell Biol. 1994 Mar;14(3):1964-71. doi: 10.1128/mcb.14.3.1964. Mol Cell Biol. 1994. PMID: 7509449 Free PMC article.
The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R.
Schumacher C, Knudsen BS, Ohuchi T, Di Fiore PP, Glassman RH, Hanafusa H. Schumacher C, et al. Among authors: glassman rh. J Biol Chem. 1995 Jun 23;270(25):15341-7. doi: 10.1074/jbc.270.25.15341. J Biol Chem. 1995. PMID: 7797522
Breast cancer (metastatic).
Stebbing J, Glassman R. Stebbing J, et al. Among authors: glassman r. Clin Evid. 2004 Jun;(11):2266-99. Clin Evid. 2004. PMID: 15652111 Updated. Review. No abstract available.
65 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback